Diagnostic approach to autoimmune hepatitis

References

• Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006 Jan;5(354):54–66.
   Web of Science ®Google Scholar
• Zachou K, Muratori P, Koukoulis GK, et al. Review article: autoimmune hepatitis - Current management and challenges. Aliment Pharmacol Ther. 2013;38:887–913.
   PubMed Web of Science ®Google Scholar
• Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998–1005.
   PubMed Web of Science ®Google Scholar
• Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31: 929–938.
   PubMed Web of Science ®Google Scholar
• Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169–176.
   PubMed Web of Science ®Google Scholar
• Feld JJ, Dinh H, Arenovich T, et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005;42:53–62.
   PubMed Web of Science ®Google Scholar
• Kogan J, Safadi R, Ashur Y, et al. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients. J Clin Gastroenterol. 2002;35:75–81.
   PubMed Web of Science ®Google Scholar
• Granito A, Muratori L, Pappas G, et al. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients. Aliment Pharmacol Ther. 2005 May 15;21:1273–1277.
   PubMed Web of Science ®Google Scholar
• Muratori P, Granito A, Quarneti C, et al. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol. 2009;50:1210–1218.
   PubMed Web of Science ®Google Scholar
• Maggiore G, Porta G, Bernard O, et al. Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr. 1990;116:280–282.
   PubMed Web of Science ®Google Scholar
• Miyake Y, Iwasaki Y, Terada R, et al. Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther. 2006 May;1(23):1347–1353.
   Web of Science ®Google Scholar
• Kessler WR, Cummings OW, Eckert G, et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol. 2004;2:625–631.
   PubMed Web of Science ®Google Scholar
• Muratori P, Lalanne C, Bianchi G, et al. Predictive factors of poor response to therapy in autoimmune hepatitis. Dig Liver Dis. 2016;48:1078–1081.
   PubMedGoogle Scholar
• Waldenstro¨M J. Leber, Blutprotein und Nahrungseiweiss. Deutsch Z Verdaustoffwechselkr. 1950;15:113–119.
   Google Scholar
• Mackay IR, Cowling DC, Taft LI. Lupoid hepatitis. Lancet. 1956;271:1323–1326.
   PubMed Web of Science ®Google Scholar
• Beisel C, Weiler-Normann C, Teufel A, et al. Association of autoimmune hepatitis and systemic lupus erythematodes: a case series and review of the literature. World J Gastroenterol. 2014 Sep;21(20):12662–12667.
   Web of Science ®Google Scholar
• Kaw R, Gota C, Bennett A et al. Lupus-related hepatitis: complication of lupus or autoimmune association? Case report and review of the literature. Dig Dis Sci. 2006 Apr;51:813–818.
   PubMed Web of Science ®Google Scholar
• Czaja A, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci. 1996;41:305–314.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology. 2010;139:54–72.
   Web of Science ®Google Scholar
• European Association for the Study of the Liver et al. EASL Clinical Practice Guidelines: autoimmune hepatitis. J Hepatol. 2015;63:971–1004.
   Google Scholar
• Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol. 2000;32:181–197.
   PubMed Web of Science ®Google Scholar
• Muratori P, Granito A, Pappas G, et al. Autoimmune liver disease 2007. Mol Aspects Med. 2008;29:96–102.
   PubMed Web of Science ®Google Scholar
• Manns MP, Johnson EF, Griffin KJ, et al. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest. 1989;83:1066–1072.
   PubMed Web of Science ®Google Scholar
• Muratori L, Parola M, Ripalti A, et al. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut. 2000;46:553–561.
   PubMed Web of Science ®Google Scholar
• Kanzler S, Weidemann C, Gerken G, et al. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol. 1999;31:635–640.
   PubMed Web of Science ®Google Scholar
• Liberal R, Mieli-Vergani G, Vergani D. Contemporary issues and future directions in autoimmune hepatitis. Expert Rev Gastroenterol Hepatol. 2016 Jun;3:1–12.
   Google Scholar
• Muratori L, Deleonardi G, Lalanne C, et al. Autoantibodies in autoimmune hepatitis. Dig Dis. 2015;33(Suppl 2):65–69.
   PubMed Web of Science ®Google Scholar
• Czaja AJ. Homburger HA. Autoantibodies in liver disease. Gastroenterology. 2001;120:239–249..
   PubMed Web of Science ®Google Scholar
• Vierling JM. Autoimmune hepatitis and overlap syndromes: diagnosis and management. Clin Gastroenterol Hepatol. 2015 Nov;13:2088–2108.
   PubMed Web of Science ®Google Scholar
• Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis. 2010 Aug;69:1420–1422.
   PubMed Web of Science ®Google Scholar
• Roberts EA, Schilsky ML. American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008 Jun;47:2089–2111.
   PubMed Web of Science ®Google Scholar
• Vergani D, Alvarez F, Bianchi FB, et al. Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41:677–683.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Cassani F, Cataleta M, et al. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci. 1997;42:1688–1696.
   PubMed Web of Science ®Google Scholar
• Cassani F, Bianchi FB, Lenzi M, et al. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol. 1985;38:801–805.
   PubMed Web of Science ®Google Scholar
• Muratori P, Granito A, Pappas G, et al. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol. 2009;104:1420–1425.
   PubMed Web of Science ®Google Scholar
• Healey R, Corless L, Gordins P, et al. Do anti-smooth muscle antibodies predict development of autoimmune hepatitis in patients with normal liver function? - A retrospective cohort review. Autoimmun Rev. 2016;15:668–672.
   PubMed Web of Science ®Google Scholar
• Bottazzo GF, Florin-Christensen A, Fairfax A, et al. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol. 1976 May;29:403–410.
   PubMed Web of Science ®Google Scholar
• Dalekos GN, Zachou K, Liaskos C, et al. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview. Eur J Intern Med. 2002;13:293–303.
   PubMedGoogle Scholar
• Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis. 2004 Oct;15(1):2.
   Google Scholar
• Cassani F, Cataleta M, Valentini P, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology. 1997;26:561–566.
   PubMed Web of Science ®Google Scholar
• Muratori P, Muratori L, Stroffolini T, et al. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol. 2003;131:118–121.
   PubMed Web of Science ®Google Scholar
• Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol. 1979 Dec;38(3):621–628.
   PubMed Web of Science ®Google Scholar
• Muratori P, Muratori L, Agostinelli D, et al. Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity. 2002;35:497–500.
   PubMed Web of Science ®Google Scholar
• Granito A, Muratori L, Muratori P, et al. Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol. 2006;59:280–284.
   PubMed Web of Science ®Google Scholar
• Fusconi M, Cassani F, Zauli D, et al. Anti-actin antibodies: a new test for an old problem. J Immunol Methods. 1990 Jun;12(130):1–8.
   Web of Science ®Google Scholar
• Cassani F, Fusconi M, Bianchi FB, et al. Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies. Clin Exp Immunol. 1987;68:588–595.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Cassani F, Cataleta M, et al. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology. 1996;24:1068–1073.
   PubMed Web of Science ®Google Scholar
• Czaja AJ. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol. 1999 Mar;30:394–401.
   PubMed Web of Science ®Google Scholar
• Couto CA, Bittencourt PL, Porta G, et al. Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis. Hepatology. 2014;59:592–600.
   PubMed Web of Science ®Google Scholar
• Manns MP, Griffin KJ, Sullivan KF, et al. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest. 1991;88:1370–1378.
   PubMed Web of Science ®Google Scholar
• Klein R, Zanger UM, Berg T, et al. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes. Clin Exp Immunol. 1999;118:290–297.
   PubMed Web of Science ®Google Scholar
• Duclos-Vallée JC, Hajoui O, Yamamoto AM, et al. Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies. Gastroenterology. 1995;10:470–476.
   Web of Science ®Google Scholar
• Muratori L, Lenzi M, Ma Y, et al. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut. 1995;37:406–412.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology. 1992 Oct;103:1290–1295.
   PubMed Web of Science ®Google Scholar
• Dalekos GN, Makri E, Loges S, et al. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece. Eur J Gastroenterol Hepatol. 2002;14:35–42.
   PubMed Web of Science ®Google Scholar
• Ferri S, Muratori L, Quarneti C, et al. Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. J Hepatol. 2009 Jun;50(6):1093–1101.
   PubMed Web of Science ®Google Scholar
• Nishioka M, Morshed SA, Kono K, et al. Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. J Hepatol. 1997 May;26(5):992–1000.
   PubMed Web of Science ®Google Scholar
• Muratori P, Muratori L, Verucchi G, et al. Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis. 2003 Nov;15(37):1320–1326.
   Web of Science ®Google Scholar
• Muratori P, Muratori L, Guidi M, et al. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis. 2005 Feb;15(40):501–507.
   Web of Science ®Google Scholar
• Muratori L, Cataleta M, Muratori P, et al. Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut. 1998;42:721–726.
   PubMed Web of Science ®Google Scholar
• Kerkar N, Choudhuri K, Ma Y, et al. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol. 2003;170:1481–1489.
   PubMed Web of Science ®Google Scholar
• Muratori L, Zauli D, Giostra F, et al. LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment. J Hepatol. 1993 Jun;18(2):259–260.
   PubMed Web of Science ®Google Scholar
• Martini E, Abuaf N, Cavalli F, et al. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology. 1988 Nov-Dec;8(6):1662–1666.
   PubMed Web of Science ®Google Scholar
• Lenzi M, Manotti P, Muratori L, et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut. 1995;36:749–754.
   PubMed Web of Science ®Google Scholar
• Abuaf N, Johanet C, Chretien P, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology. 1992;16:892–898.
   PubMed Web of Science ®Google Scholar
• Han S, Tredger M, Gregorio GV, et al. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology. 1995;21:58–62.
   PubMed Web of Science ®Google Scholar
• Lapierre P, Hajoui O, Homberg JC, et al. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology. 1999;116:643–649.
   PubMed Web of Science ®Google Scholar
• Muratori L, Sztul E, Muratori P, et al. Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1. Hepatology. 2001 Sep;34(3):494–501.
   PubMed Web of Science ®Google Scholar
• Muratori L, Cataleta M, Muratori P, et al. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques. J Immunol Methods. 1995 Dec 1;187:259–264.
   PubMed Web of Science ®Google Scholar
• Wies I, Brunner S, Henninger J, et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet. 2000 Apr 29;355(9214):1510–1515.
   PubMed Web of Science ®Google Scholar
• Costa M, Rodríguez-Sánchez JL, Czaja AJ, et al. Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis. Clin Exp Immunol. 2000 Aug;121(2):364–374.
   PubMed Web of Science ®Google Scholar
• Palioura S, Sherrer RL, Steitz TA, et al. The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation. Science. 2009 Jul 17;325(5938):321–325.
   PubMed Web of Science ®Google Scholar
• Efe C, Ozaslan E, Wahlin S, et al. Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study. Liver Int. 2013 Feb;33(2):190–196.
   PubMed Web of Science ®Google Scholar
• Eyraud V, Chazouilleres O, Ballot E, et al. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study. Liver Int. 2009 Jul;29(6):857–864.
   PubMed Web of Science ®Google Scholar
• Montano-Loza AJ, Shums Z, Norman GL, et al. Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis. Liver Int. 2012 Jan;32:85–92.
   PubMed Web of Science ®Google Scholar
• Ma Y, Okamoto M, Thomas MG, et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 2002;35:658–664.
   PubMed Web of Science ®Google Scholar
• Zauli D, Ghetti S, Grassi A, et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology. 1997;25:1105–1107.
   PubMed Web of Science ®Google Scholar
• Weiner M, Segelmark M. The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). Autoimmun Rev. 2016 Oct;15:978–982.
   PubMed Web of Science ®Google Scholar
• Terjung B, Herzog V, Worman HJ, et al. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology. 1998;28:332–340.
   PubMed Web of Science ®Google Scholar
• Terjung B, Worman HJ, Herzog V, et al. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin Exp Immunol. 2001;126:37–46.
   PubMed Web of Science ®Google Scholar
• Terjung B, Spengler U, Sauerbruch T, et al. “Atypical p-ANCA” in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology. 2000;119:310–322.
   PubMed Web of Science ®Google Scholar
• Yoshioka M, Mizuno M, Morisue Y, et al. Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases. Acta Med Okayama. 2002 Apr;56(2):99–105.
   PubMed Web of Science ®Google Scholar
• Hausdorf G, Roggenbuck D, Feist E, et al. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA–revival of a disease-activity marker in autoimmune hepatitis. Clin Chim Acta. 2009;408:19–24.
   PubMed Web of Science ®Google Scholar
• Villalta D, Mytilinaiou MG, Elsner M, et al. Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases. Clin Chim Acta. 2015 Oct;23(450):1–5.
   Web of Science ®Google Scholar
• Treichel U, Poralla T, Hess G, et al. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology. 1990;11:606–612.
   PubMed Web of Science ®Google Scholar
• Crivelli O, Lavarini C, Chiaberge E, et al. Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol. 1983;54:232–238.
   PubMed Web of Science ®Google Scholar
• Strassburg CP, Obermayer-Straub P, Alex B. Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis. Gastroenterology. 1996 Dec;111:1576–1586.
   PubMed Web of Science ®Google Scholar
• O’Brien C, Joshi S, Feld JJ, et al. Long-term follow-up of antimitochondrial antibody-positive autoimmune epatiti. Hepatology. 2008 Aug;48(2):550–556.
   PubMed Web of Science ®Google Scholar
• Nezu S, Tanaka A, Yasui H, et al. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2006;21:1448–1454.
   PubMed Web of Science ®Google Scholar
• Melo ES, Abrantes-Lemos CP, Porta G, et al. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis. Gastroenterol Hepatol. 2006 May;21(5):887–893.
   Web of Science ®Google Scholar
• Muratori P, Efe C, Muratori L, et al. Clinical implications of AMA seropositivity in Autoimmune Hepatitis: a multicentre study. Eur J Gastroenterol Hepatol. 2017. doi:10.1097/MEG.0000000000000870. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Mitchison HC, Bassendine MF, Hendrick A, et al. Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology. 1986;6:1279–1284.
   PubMed Web of Science ®Google Scholar
• Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet. 1996 Nov;23(348):1399–1402.
   Web of Science ®Google Scholar
• Muratori P, Lalanne C, Fabbri, et al. Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype. Aliment Pharmacol Ther. 2015;41:1281–1287.
   PubMed Web of Science ®Google Scholar
• Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 1997;25:541–547.
   PubMed Web of Science ®Google Scholar
• Selmi C, Ceribelli A, Generali, et al. Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years. Autoimmun Rev. 2016;15:162–166.
   PubMed Web of Science ®Google Scholar
• Holdener M, Hintermann E, Bayer M, et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med. 2008 Jun 9;205:1409–1422.
   PubMed Web of Science ®Google Scholar
• Hintermann E, Ehser J, Christen U. The CYP2D6 animal model: how to induce autoimmune hepatitis in mice. J Vis Exp. 2012;60:1–7.
   PubMed Web of Science ®Google Scholar
• Yuksel M, Wang Y, Tai N, et al. A novel “humanized mouse” model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. Hepatology. 2015;62:1536–1550.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Pappas G, Agostinelli D, et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the ‘acute’ type. QJM. 2004;97:407–412.
   PubMed Web of Science ®Google Scholar
• Manns MP, Czaja AJ, Gorham JD, et al. American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–2213.
   PubMed Web of Science ®Google Scholar
• Panayi V, Froud OJ, Vine L, et al. The natural history of autoimmune hepatitis presenting with jaundice. Eur J Gastroenterol Hepatol. 2014;26:640–645.
   PubMed Web of Science ®Google Scholar
• Okano N, Yamamoto K, Sakaguchi K, et al. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol Res. 2003;25:263–270.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Carpenter HA. Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis. Liver Int. 2003 Apr;23:116–123.
   PubMed Web of Science ®Google Scholar
• Miao Q, Bian Z, Tang R, et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol. 2015;48:226–235.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Carpenter HA. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology. 2001 Oct;34:659–665.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Muratori P, Muratori L, et al. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int. 2004;24:322–329.
   PubMed Web of Science ®Google Scholar
• Kirstein MM, Metzler F, Geiger E, et al. Prediction of short- and long-term outcome in patients with autoimmune hepatitis. Hepatology. 2015;62:1524–1535.
   PubMed Web of Science ®Google Scholar
• Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 1996 Mar;110:848–857.
   PubMed Web of Science ®Google Scholar
• Yoshizawa K, Matsumoto A, Ichijo T, et al. Long-term outcome of Japanese patients with type 1 autoimmune hepatitis. Hepatology. 2012;56:668–676.
   PubMed Web of Science ®Google Scholar
• Donaldson PT, Doherty DG, Hayllar KM, et al. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology. 1991;13:701–706.
   PubMed Web of Science ®Google Scholar
• Strettell MD, Donaldson PT, Thomson LJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology. 1997;112:2028–2035.
   PubMed Web of Science ®Google Scholar
• Muratori P, Czaja AJ, Muratori L, et al. Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol. 2005;11(12):1862–1866.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Strettell MD, Thomson LJ, et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology. 1997;25:317–323.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Carpenter HA, Santrach PJ, et al. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology. 1993;105:1502–1507.
   PubMed Web of Science ®Google Scholar
• de Boer YS, van Gerven NM, Zwiers A, et al. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology. 2014;147:443–452.
   PubMed Web of Science ®Google Scholar
• Yoshizawa K, Ota M, Katsuyama Y, et al. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. J Hepatol. 2005;42:578–584.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Souto EO, Bittencourt PL, et al. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol. 2002 Sep;37(3):302–308.
   PubMed Web of Science ®Google Scholar
• Fainboim L, Marcos Y, Pando M, et al. Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype. Hum Immunol. 1994;41:146–150.
   PubMed Web of Science ®Google Scholar
• Bittencourt PL, Goldberg AC, Cançado EL, et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol. 1999;94:1906–1913.
   PubMed Web of Science ®Google Scholar
• Ma Y, Bogdanos DP, Hussain MJ, et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology. 2006;130:868–882.
   PubMed Web of Science ®Google Scholar
• Czaja AJ, Kruger M, Santrach PJ, et al. Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol. 1997;92:2197–2200.
   PubMed Web of Science ®Google Scholar
• Jurado A, Cárdaba B, Jara P, et al. Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens. J Hepatol. 1997;26:983–991.
   PubMed Web of Science ®Google Scholar
• Djilali-Saiah I, Fakhfakh A, Louafi H, et al. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J Hepatol. 2006;45:844–850.
   PubMed Web of Science ®Google Scholar
• Teufel A, Weinmann A, Kahaly GJ, et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010;44:208–213.
   PubMed Web of Science ®Google Scholar
• Muratori P, Fabbri A, Lalanne C, et al. Autoimmune liver disease and concomitant extrahepatic autoimmune disease. Eur J Gastroenterol Hepatol. 2015;27:1175–1179.
   PubMed Web of Science ®Google Scholar
• Efe C, Wahlin S, Ozaslan E, et al. Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol. 2012;24:531–534.
   PubMed Web of Science ®Google Scholar
• Cui B, Abe M, Hidata S, et al. Autoimmune hepatitis associated with Graves’ disease. Intern Med. 2003;42:331–335.
   PubMed Web of Science ®Google Scholar
• Inoue K, Okajima T, Tanaka E, et al. A case of Graves’ disease associated with autoimmune hepatitis and mixed connective. Endocr J. 1999;46:173–177.
   PubMed Web of Science ®Google Scholar
• Gurudu SR, Mittal SK, Shaber M, et al. Autoimmune epatiti associated with autoimmune hemolytic anemia and anticardiolipin antibody syndrome. Dig Dis Sci. 2000;45:1878–1880.
   PubMed Web of Science ®Google Scholar
• Nobili V, Liaskos C, Luigi G, et al. Autoimmune thyroiditis associated with autoimmune hepatitis. Thyroid. 2005;15:1193–1195.
   PubMed Web of Science ®Google Scholar
• Dourakis SP, Michael AE, Papanikolaou IS, et al. Autoimmune hepatitis associated with the antiphospholipid syndrome. Eur J Gastroenterol Hepatol. 2001;13:591–593.
   PubMed Web of Science ®Google Scholar
• Hadjigogos K, Marinaki P. Autoimmune hepatitis and the antiphospholipid antibody syndrome. A case report. Panminerva Med. 2003;45:223–224.
   PubMed Web of Science ®Google Scholar
• Arvola T, Mustalahti K, Saha MT, et al. Celiac disease, thyrotoxicosis, and autoimmune hepatitis in a child. J Pediatr Gastroenterol Nutr. 2002;35:90–92.
   PubMed Web of Science ®Google Scholar
• Biecker E, Stieger M, Zimmermann A, et al. Autoimmune hepatitis, cryoglobulinaemia and untreated coeliac disease: a case report. Eur J Gastroenterol Hepatol. 2003;15:423–427.
   PubMed Web of Science ®Google Scholar
• Bridoux-Henno L, Dabadie A, Briard D, et al. A case of celiac disease presenting with autoimmune hepatitis and erythroblastopenia. J Pediatr Gastroenterol Nutr. 2001;33:616–619.
   PubMed Web of Science ®Google Scholar
• Caiulo VA, Averbene C, Olmi S, et al. Celiac disease associated with chronic autoimmune hepatitis. Description of a case. Minerva Pediatr. 1993;45:511–513.
   PubMedGoogle Scholar
• Fujiwara K, Kono T, Ishii M, et al. Lupus erythematosus panniculitis in a patient with autoimmune hepatitis. Acta Derm Venereol. 2000;80:373–375.
   PubMed Web of Science ®Google Scholar
• Chazouillères O. Overlap syndromes. Dig Dis. 2015;33:181–187.
   PubMed Web of Science ®Google Scholar